Company Listing
Fovea Pharmaceuticals

Fovea discovered and developed innovative drugs for the treatment of retinal diseases such as age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy and macular edema. The company was acquired by sanofi-aventis for up to €370 million in October 2009.

BACK
Location
Paris, France

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Fovea discovered and developed innovative drugs for the treatment of retinal diseases such as age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy and macular edema. The company was acquired by sanofi-aventis for up to €370 million in October 2009.

Location
Paris, France
BACK
 
Copyright Abingworth 2017